Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(63 sites)
United States
UCI Medical Center, Orange, California Stanford Medicine, Palo Alto, California UC Davis Comprehensive Cancer Center, Sacramento, California University of Colorado Cancer Center, Denver, Colorado Georgetown University Medical Center, Washington D.C., District of Columbia University of Miami, Coral Gables, Florida University of Chicago, Chicago, Illinois Mass General Hospital, Boston, Massachusetts Dana-Farber Cancer Institute, Boston, Massachusetts Henry Ford Cancer Institute, Detroit, Michigan Washington University School of Medicine, St Louis, Missouri NYU Langone Health, New York, New York Memorial Sloan Kettering Cancer Center, New York, New York Atrium Health Levine Cancer Institute, Charlotte, North Carolina Ohio State University, Columbus, Ohio Fox Chase Cancer Center, Philadelphia, Pennsylvania Sarah Cannon Research Institute, Nashville, Tennessee MD Anderson Cancer Center, Houston, Texas NEXT Oncology - Virginia Cancer Specialists, Fairfax, Virginia University of Washington / Fred Hutchinson Cancer Center, Seattle, Washington Australia
Chris O'Brien Lifehouse, Camperdown, New South Wales Peter MacCallum Cancer Centre, Melbourne, Victoria Belgium
University Hospital Leuven, Leuven Canada
Cross Cancer Institute, Edmonton, Alberta Princess Margaret Cancer Research, Toronto, Ontario France
Centre Legon Berard, Lyon Claudius Regaud Institute, Toulouse Institute Gustave Roussy, Villejuif Germany
Cologne University Hospital, Cologne Italy
Università Politecnica Marche, Ancona IRCCS Istituto Tumori Giovanni Paolo II, Bari Istituto Europeo di Oncologia, Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Istituto Oncologico Veneto, Padova Ospedale Santa Maria delle Croci, Ravenna Istituto Nazionale Tumori Regina Elena, Rome Japan
Kanagawa Cancer Center, Kanagawa Okayama University Hospital, Okayama Kindai University Hospital, Osaka Shizuoka Cancer Center, Shizuoka National Cancer Center Hospital, Tokyo The Cancer Institute Hospital Of JFCR, Tokyo Wakayama Medical University Hospital, Wakayama Netherlands
Netherlands Cancer Institute, Amsterdam University Medical Centre Groningen, Groningen Singapore
National University Hospital Singapore, Singapore National Cancer Centre Singapore, Singapore South Korea
National Cancer Center, Gyeonggi-do Seoul National University Hospital, Seoul Yonsei University Health System, Seoul Samsung Medical Center, Seoul Spain
University Hospital of A Coruña, A Coruña UOMI Cancer Center - Clinica Tres Torres, Barcelona Vall d'Hebron University Hospital, Barcelona Gregorio Marañón Hospital, Madrid Hospital Universitario 12 de Octubre, Madrid Hospital Universitario HM Sanchinarro, Madrid Taiwan
Chung Shan Medical University Hospital, Taichung National Cheng Kung University Hospital, Tainan National Taiwan University Hospital, Taipei United Kingdom
Royal Marsden Hospital, London Christie NHS Foundation Trust, Manchester